Jon Kratochvil, an experienced scientist and lawyer, has joined ERS Genomics Ltd as head of business development and licensing for North America. ERS manages intellectual property for the Crispr-Cas9 gene editing technology co-owned by Emmanuelle Charpentier. Mr Kratochvil comes to ERS from MilliporeSigma where he managed global development for the company’s gene editing technologies.
He has also worked as a licensing manager for Abbott Diagnostics. Mr Kratochvil is an inventor on more than 40 patents and patent applications, and holds a master’s degree in microbiology and immunology and a law degree from Loyola University Chicago School of Law, US.
ERS Genomics announced the appointment on 1 March 2021
Copyright 2021 Evernow Publishing Ltd